Persistent activation of nuclear factor-kappaB by interleukin-1beta and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase
- PMID: 11742864
- DOI: 10.1161/hq1201.099424
Persistent activation of nuclear factor-kappaB by interleukin-1beta and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase
Abstract
The role of extracellular signal-regulated kinase (ERK) was studied in the signaling pathway by which interleukin-1beta (IL-1beta) increases the expression of inducible NO synthase (iNOS) in rat vascular smooth muscle cells. IL-1beta induced a rapid and transient activation of nuclear factor-kappaB (NF-kappaB), followed by a prolonged activation of NF-kappaB that was required to induce iNOS expression. Either PD98059 or U0126, selective inhibitors of ERK activation, did not influence IL-1beta-induced early activation but effectively reduced the prolonged activation of NF-kappaB and significantly reduced IL-1beta induction of iNOS. Transfection with antisense, but not sense, phosphorothioate-modified oligodeoxynucleotides directed toward ERK also reduced IL-1beta-induced prolonged NF-kappaB activation and iNOS expression. IkappaBbeta, but not IkappaBalpha degradation, induced by IL-1beta was markedly attenuated when ERK activation was inhibited and could be partially responsible for the persistent NF-kappaB activation. These data suggest that ERK activity is required for persistent NF-kappaB activation by IL-1beta that is necessary for iNOS gene expression.
Similar articles
-
Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression.J Biol Chem. 2004 Jan 9;279(2):1323-9. doi: 10.1074/jbc.M307521200. Epub 2003 Oct 27. J Biol Chem. 2004. PMID: 14581482
-
Growth factors enhance interleukin-1 beta-induced persistent activation of nuclear factor-kappa B in rat vascular smooth muscle cells.Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1811-6. doi: 10.1161/01.atv.0000037679.60584.3f. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426209
-
Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells.Hypertens Res. 2000 Nov;23(6):659-67. doi: 10.1291/hypres.23.659. Hypertens Res. 2000. PMID: 11131279
-
A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.J Biochem. 2001 Apr;129(4):585-91. doi: 10.1093/oxfordjournals.jbchem.a002894. J Biochem. 2001. PMID: 11275558
-
Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB.Glia. 2003 Jan 15;41(2):152-60. doi: 10.1002/glia.10168. Glia. 2003. PMID: 12509805
Cited by
-
Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.Am J Physiol Cell Physiol. 2009 Jun;296(6):C1310-20. doi: 10.1152/ajpcell.00573.2008. Epub 2009 Apr 15. Am J Physiol Cell Physiol. 2009. PMID: 19369446 Free PMC article.
-
Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.Diabetes. 2009 Oct;58(10):2355-64. doi: 10.2337/db09-0432. Epub 2009 Jul 8. Diabetes. 2009. PMID: 19587355 Free PMC article.
-
Mechanical signals control SOX-9, VEGF, and c-Myc expression and cell proliferation during inflammation via integrin-linked kinase, B-Raf, and ERK1/2-dependent signaling in articular chondrocytes.Arthritis Res Ther. 2010;12(3):R106. doi: 10.1186/ar3039. Epub 2010 May 28. Arthritis Res Ther. 2010. PMID: 20509944 Free PMC article.
-
Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts.PLoS One. 2013 Apr 18;8(4):e61393. doi: 10.1371/journal.pone.0061393. Print 2013. PLoS One. 2013. PMID: 23637826 Free PMC article.
-
Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases.Free Radic Biol Med. 2008 Apr 1;44(7):1232-45. doi: 10.1016/j.freeradbiomed.2007.12.025. Epub 2008 Jan 22. Free Radic Biol Med. 2008. PMID: 18211830 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous